June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 23, 2025

Higher SCFAs in Blood Predict Diabetes Risk

New research following Spanish adults over 7 years found that higher levels of specific gut-derived fatty acids in the blood—especially butyrate and isobutyrate—were linked to an increased risk of developing type 2 diabetes, offering insights into early risk prediction.

Conexiant

June 23, 2025

IBS Relief: Which Diet Wins?

A randomized trial found that while both Mediterranean and low-FODMAP diets improved symptoms in patients with nonconstipated IBS, the low-FODMAP diet led to greater reductions in symptom severity.

Conexiant

June 23, 2025

Fidaxomicin Effective, Well-Tolerated in Pediatric CDI

A multicenter study of pediatric patients treated with fidaxomicin for C difficile found over half were cured by two weeks, and only one in five had a recurrence within two months.

Conexiant

June 20, 2025

Gut Bacteria Predict Chemotherapy-Related Heart Damage

Specific gut bacteria correlate with biomarkers indicating increased risk of cardiotoxicity in breast cancer patients before chemotherapy treatment.

Conexiant

June 10, 2025

FDA Pledges Week-Long Drug Reviews

New leadership outlines accelerated approval processes, AI integration, and food additive restrictions to address the chronic disease epidemic

Conexiant

June 09, 2025

EHR Prompts Cut Antibiotic Use by 35%

A 92-hospital trial found that simple prompts in electronic health records helped reduce the use of broad-spectrum antibiotics in low-risk abdominal infection cases—without increasing ICU stays or length of hospitalization.

Conexiant

June 06, 2025

Lower-Dose Treatment Effective in Anal Cancer Trial, Study

In a recent clinical trial, researchers found that a reduced-dose chemoradiotherapy regimen for early-stage anal cancer may be comparable to standard treatment in achieving short-term tumor response, while causing fewer serious side effects.

Conexiant

June 06, 2025

FDA Monthly Round-up: Key May Updates

May’s FDA approvals include the first at-home HPV test, a blood-based Alzheimer’s diagnostic, biosimilars, AI-enabled imaging tools, and novel therapies across cardiology, pulmonology, neurology, gastroenterology, and more.

Conexiant